You are here

Article Text

Article menu
PDF
Letters
Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population
  1. Narumi Hasebe1,
  2. Aya Kawasaki1,
  3. Ikue Ito1,
  4. Manabu Kawamoto2,
  5. Minoru Hasegawa3,
  6. Manabu Fujimoto3,
  7. Hiroshi Furukawa4,
  8. Shigeto Tohma4,
  9. Takayuki Sumida5,
  10. Kazuhiko Takehara3,
  11. Shinichi Sato6,
  12. Yasushi Kawaguchi2,
  13. Naoyuki Tsuchiya1
  1. 1Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
  2. 2Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
  3. 3Department of Dermatology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
  4. 4Clinical Research Centre for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organisation, Sagamihara, Japan
  5. 5Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
  6. 6Department of Dermatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
  1. Correspondence to Dr Naoyuki Tsuchiya, Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan; tsuchiya-tky{at}umin.ac.jp

http://dx.doi.org/10.1136/annrheumdis-2011-201091

Statistics from Altmetric.com

    Susceptibility genes to systemic sclerosis (SSc) are substantially shared by other autoimmune diseases.1 UBE2L3, encoding a ubiquitin-conjugating enzyme, was associated with systemic lupus erythematosus (SLE)2 3 and rheumatoid arthritis (RA).4 In this study, we examined whether UBE2L3 is associated with SSc.

    A case–control association study was performed on 391 Japanese patients and 1010 healthy controls recruited at Kanazawa University, the University of Tokyo, Institute of Rheumatology, Tokyo Women's Medical University and Sagamihara Hospital, National Hospital Organisation. All patients and …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions